Anavex Life Sciences Corp.
Utility Patent Applications

Last updated:

List of all Anavex Life Sciences Corp. patents 15 in total

Status Patent
Application
Utility: ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS External link
Filling date: 9 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT External link
Filling date: 9 Sep 2025 Issue date: 21 Jul 2022
Application
Utility: ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS External link
Filling date: 9 Sep 2025 Issue date: 12 May 2022
Application
Utility: TREATMENT OF CARDIAC DYSFUNCTION External link
Filling date: 9 Sep 2025 Issue date: 31 Mar 2022
Application
Utility: Neurodevelopmental Disorder Therapy External link
Filling date: 9 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE HYDROCHLORIDE, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS External link
Filling date: 9 Sep 2025 Issue date: 22 Jul 2021
Application
Utility: Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazi- ne and salts thereof External link
Filling date: 9 Sep 2025 Issue date: 1 Jul 2021
Application
Utility: SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY External link
Filling date: 9 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION External link
Filling date: 9 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy External link
Filling date: 9 Sep 2025 Issue date: 18 Feb 2021
Application
Utility: Neurodevelopmental Disorder Therapy External link
Filling date: 9 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy External link
Filling date: 9 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: Anavex2-73 for the Treatment of Alzheimer's Disease External link
Filling date: 9 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE HYDROCHLORIDE, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS External link
Filling date: 9 Sep 2025 Issue date: 21 Nov 2019

Showing 1 to 15 of 15 patents.